Correlation between patient-derived intestinal organoids and clinical responses to CFTR modulators in people with cystic fibrosis homozygous for F508del
Journal of Cystic Fibrosis · 2025
DOI: 10.1016/j.jcf.2025.08.011 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Cystic Fibrosis, 2025. Verfasst von Noelia Rodriguez Mier und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Development and Regeneration, Woman and Child Unit, CF Research Lab, KU Leuven, Leuven, Belgium; Department of Pediatrics, Pediatric Pu…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Organoids, Aminophenols. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: King Baudouin Foundation.
Abstract (Originalsprache)
BACKGROUND: Patient-derived intestinal organoids (PDIOs) are an in vitro tool used to predict clinical responses to CFTR modulators in people with cystic fibrosis (pwCF). Although strong genotype-based correlations have been observed, individual responses among F508del homozygous pwCF remain variable. We aimed to assess this correlation specifically within this group. METHODS: A retrospective multi-center study included 60 F508del homozygous pwCF from six Belgian CF centers. The 15 highest and 15 lowest PDIO responders to tezacaftor/ivacaftor (TI) and elexacaftor/tezacaftor/ivacaftor (ETI) were selected based on Forskolin-induced swelling (FIS) assay results. Clinical outcomes-sweat chloride concentration (SCC), spirometry, BMI, pulmonary exacerbations, and IV antibiotic use-were measured before and after treatment. Additionally, transcriptomics and 13 CFTR SNPs were compared between high and low responders to TI to assess whether variants within CFTR contribute to phenotypic variability. RESULTS: Baseline characteristics were similar between low and high PDIO responders, except for lower pre-treatment SCC in high TI responders. No significant differences in clinical outcomes were observed between groups after treatment. PDIO responses were higher with ETI than TI (p < 0.001). PDIO response magnitude was significantly associated with changes in SCC and ppFEV1 (p < 0.001). No differences in SNPs or transcriptomics were found. CONCLUSION: While high and low PDIO response groups did not differ in clinical outcomes individually, PDIO response magnitude was significantly associated with SCC and ppFEV1 changes when TI and ETI data were combined, suggesting its potential as a biomarker for modulator treatment efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Development and Regeneration, Woman and Child Unit, CF Research Lab, KU Leuven, Leuven, Belgium; Department of Pediatrics, Pediatric Pulmonology, University Hospital Leuven, Leuven, Belgium. Electronic add…
- Department of Development and Regeneration, Woman and Child Unit, CF Research Lab, KU Leuven, Leuven, Belgium; Department of Pediatrics, Pediatric Pulmonology, University Hospital Leuven, Leuven, Belgium.
- Department of Chronic Diseases and Metabolism (CHROMETA), Translational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Flanders, Belgium.
- Department of Pediatrics, Pediatric Pulmonology, University Hospital Brussels, Brussels, Belgium.
- Department of Pediatrics, Pediatric Gastro-enterology, Ghent University Hospital, Ghent, Belgium.
- Department of Pediatrics, Pediatric Pulmonology, Antwerp University Hospital, Edegem, Belgium.
Förderung
- King Baudouin Foundation
Zitieren
APA
Rodriguez Mier, N., Cuyx, S., De Boeck, K., Proesmans, M., Boon, M., Dupont, L., Arnauts, K., De Wachter, E., Van Biervliet, S., Lequesne, M., Nowé, V., Boboli, H., Ramalho, A. S., Vermeulen, F., & Belgian Organoid Project (2025). Correlation between patient-derived intestinal organoids and clinical responses to CFTR modulators in people with cystic fibrosis homozygous for F508del. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2025.08.011
Vancouver
Rodriguez Mier N, Cuyx S, De Boeck K, Proesmans M, Boon M, Dupont L, et al. Correlation between patient-derived intestinal organoids and clinical responses to CFTR modulators in people with cystic fibrosis homozygous for F508del. Journal of Cystic Fibrosis. 2025. doi:10.1016/j.jcf.2025.08.011
BibTeX
@article{RodriguezMier2025,
author = {Rodriguez Mier, Noelia and Cuyx, Senne and De Boeck, Kris and Proesmans, Marijke and Boon, Mieke and Dupont, Lieven and Arnauts, Kaline and De Wachter, Elke and Van Biervliet, Stephanie and Lequesne, Monique and Nowé, Vicky and Boboli, Hedwige and Ramalho, Anabela Santo and Vermeulen, François and Belgian Organoid Project, Belgian Organoid Project},
title = {Correlation between patient-derived intestinal organoids and clinical responses to CFTR modulators in people with cystic fibrosis homozygous for F508del},
journal = {Journal of Cystic Fibrosis},
year = {2025},
doi = {10.1016/j.jcf.2025.08.011}
}
EUVIMED